ADAMTS1 is regulated by interleukin-1β, not by hypoxia, in chondrosarcoma

Human Pathology

Volumn 38, Issue 1, 2007, Pages 86-94

  Kalinski, Thomas ^a   Krueger, Sabine ^a   Sel, Saadettin ^b   Werner, Kerstin ^a   Röpke, Martin ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

ADAMTS1; Chondrosarcoma; Hypoxia; Interleukin 1 ; VEGF A

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS 1 PROTEIN; INTERLEUKIN 1BETA; PROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CHONDROSARCOMA; CONTROLLED STUDY; DOWN REGULATION; ENCHONDROMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAM PROTEINS; ADULT; AGED; BLOTTING, WESTERN; BONE NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CHONDROSARCOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845289447     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.06.012     Document Type: Article

References (26)

1. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
2. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
3. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 (1999) 9-22
4. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20 (2002) 4368-4380
5. Kalinski T., Krueger S., Sel S., Werner K., Ropke M., and Roessner A. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1β. Cancer 106 (2006) 2028-2038
6. Luque A., Carpizo D.R., and Iruela-Arispe M.L. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem 278 (2003) 23656-23665
7. Iruela-Arispe M.L., Carpizo D., and Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci 995 (2003) 183-190
8. Porter S., Clark I.M., Kevorkian L., and Edwards D.R. The ADAMTS metalloproteinases. J Biochem 386 (2005) 15-27
9. Kuno K., Okada Y., Kawashima H., et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 478 (2000) 241-245
10. Rodriguez-Manzaneque J.C., Westling J., Thai S.N., et al. ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem Biophys Res Commun 293 (2002) 501-508
11. Voronov E., Shouval D.S., Krelin Y., et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 100 (2003) 2645-2650
12. 2-regulated gene expression. FASEB J 16 (2002) 1151-1162
13. Fang J., Yan L., Shing Y., and Moses M.A. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res 61 (2001) 5731-5735
14. Kalinski T., Krueger S., Pelz A.F., et al. Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease. Virchows Arch 446 (2005) 287-299
15. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
16. Wachsmuth L., Bau B., Fan Z., Pecht A., Gerwin N., and Aigner T. ADAMTS-1, a gene product of articular chondrocytes in vivo and in vitro, is downregulated by interleukin 1beta. J Rheumatol 31 (2004) 315-320
17. Kevorkian L., Young D.A., Darrah C., et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50 (2004) 131-141
18. Porter S., Scott S.D., Sassoon E.M., et al. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res 10 (2004) 2429-2440
19. Masui T., Hosotani R., Tsuji S., et al. Expression of METH-1 and METH-2 in pancreatic cancer. Clin Cancer Res 7 (2001) 3437-3443
20. Ayala G., Liu C., Nicosia R., Horowitz S., and Lackman R. Microvasculature and VEGF expression in cartilaginous tumors. Hum Pathol 31 (2000) 341-346
21. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
22. Barbera-Guillem E., Nyhus J.K., Wolford C.C., Friece C.R., and Sampsel J.W. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62 (2002) 7042-7049
23. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503-508
24. Francannet C., Cohen-Tanugi A., Le Merrer M., Munnich A., Bonaventure J., and Legeai-Mallet L. Genotype-phenotype correlation in hereditary multiple exostoses. J Med Genet 38 (2001) 430-434
25. Demircan K., Hirohata S., Nishida K., et al. ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 52 (2005) 1451-1460
26. Lin C., McGough R., Aswad B., Block J.A., and Terek R. Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res 22 (2004) 1175-1181